Johnson & Johnson Announces Advance Purchase Agreement with th... - 29 March 2021 18:56

NEW BRUNSWICK, N.J., March 29, 2021 /PRNewswire-AsiaNet/ -- - Up to 400 million doses of the Company's single-shot vaccine candidate will be made available to African Union member states - Availability of the vaccine is subject to national regulatory approvals - Data have demonstrated vaccine candida...

  Saxenda(R) recommended for approval by European Medicines Agen... - 27 March 2021 01:20

BAGSVÆRD, Denmark, March 26, 2021, /PRNewswire-AsiaNet/-- Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has recommended that the use of Saxenda(R) is expanded for the treatment of obesity in adolescents aged 12–17 yea...

  Airway Therapeutics Announces FDA Acceptance of IND for AT-100... - 26 March 2021 19:00

CINCINNATI, March 26, 2021 /PRNewswire-AsiaNet/ -- -- Initiating Phase 1b randomized clinical trial with initial results expected in late 2021 -- Potential for novel, preventive AT-100 to reduce incidence and severity of serious respiratory disease BPD, improving outcomes and survival in very p...

  Amplicore, Inc. Announces Closing of a Successful $4M Seed Fun... - 26 March 2021 08:39

CINCINNATI, March 26, 2021 /PRNewswire-AsiaNet/ -- Amplicore Inc. ( https://c212.net/c/link/?t=0&l=en&o=3106765-1&h=2384393405&u=https%3A%2F%2Fwww.amplicorepharma.com%2F&a=Amplicore+Inc ) , an early-stage biopharmaceutical company currently developing locally delivered and minimally invasive thera...

  Antengene Appoints Kevin Lynch as Chief Medical Officer - 26 March 2021 04:26

SHANGHAI, China and MELBOURNE, Australia, March 25, 2021 /PRNewswire-Asianet/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology...

  Antengene Appoints Bo Shan as Chief Scientific Officer - 26 March 2021 02:21

SHANGHAI, March 25, 2021 /PRNewswire-AsiaNet/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology...

  SOPHiA GENETICS and Hitachi Announce Collaboration to Advance ... - 26 March 2021 00:00

BOSTON, LAUSANNE, Switzerland and TOKYO, March 25, 2021 /PRNewswire-AsiaNet/ -- - Multi-year agreement to expand commercial footprint with world-leading genomics platform and develop R&D to unlock the potential of multimodal health data SOPHiA GENETICS SA ("SOPHiA GENETICS"), pioneer in Data-Driven Medicine, and Hitachi, L...

  China Eastern Flies Vaccines to Dominican Republic - 25 March 2021 23:33

SHANGHAI, Mar. 25, 2021 /Xinhua-AsiaNet/-- A new batch of vaccines developed by Chinese pharmaceutical companies Sinopharm and Sinovac was delivered on March 18 by China Eastern Airlines from Beijing to the Dominican Republic, according to the Shanghai-based airline. After 17 hours 34 m...

  Positive Phase III Clinical Results for EirGenix's Proposed Tr... - 25 March 2021 02:31

TAIPEI, March 23, 2021 /PRNewswire-AsiaNet/ -- In a press conference today, EirGenix, Inc. (6589.TT) announced that the Phase III clinical trial (Trial No.: EGC002, NCT03433313) of its breast cancer biosimilar, EG12014 (proposed trastuzumab biosimilar, also called EGI014), has met its primary ...

  Fishawack Health unveils an unrivaled global market access and... - 24 March 2021 23:00

LONDON, March 24, 2021 /PRNewswire-AsiaNet/ -- - Fishawack Health bolsters its strong strategic offering by acquiring PRMA Consulting – a global market access and HEOR consulting leader with significant expertise in US, EU, and Asia-Pacific markets Leading life science commercialization par...